All Stories

  1. Gender‐based differences in gamification and mobile learning

    Article • Acta Physiologica, July 2024, Wiley

    Dr Manuel Gómez-Guzmán

  2. Differing contributions of the gut microbiota to the blood pressure lowering effects induced by first‐line antihypertensive drugs

    Article • British Journal of Pharmacology, May 2024, Wiley

    Dr Manuel Gómez-Guzmán

  3. The importance of COVID-19 vaccination during lactation

    Article • Infectious Diseases Now, February 2024, Elsevier

    Dr Manuel Gómez-Guzmán

  4. Protective effect of microbiota-derived short chain fatty acids on vascular dysfunction in mice with systemic lupus erythematosus induced by toll like receptor 7 activation

    Article • Pharmacological Research, December 2023, Elsevier

    Dr Manuel Gómez-Guzmán

  5. Community pharmacy is the key to improving vitamin D levels

    Article • Exploratory Research in Clinical and Social Pharmacy, March 2023, Elsevier

    Dr Manuel Gómez-Guzmán

  6. Mineralocorticoid receptor blockade improved gut microbiota dysbiosis by reducing gut sympathetic tone in spontaneously hypertensive rats

    Article • Biomedicine & Pharmacotherapy, February 2023, Elsevier

    Dr Manuel Gómez-Guzmán

  7. Un nuevo camino en la Atención Farmacéutica: la idoneidad de la Evaluación Clínica Objetiva Estructurada

    Article • Ars Pharmaceutica (Internet), June 2022, Editorial de la Universidad de Granada

    Dr Manuel Gómez-Guzmán

  8. Vasoconstrictor and Pressor Effects of Des-Aspartate-Angiotensin I in Rat

    Article • Biomedicines, May 2022, MDPI AG

    Dr Manuel Gómez-Guzmán

  9. Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation

    Article • European Journal of Medicinal Chemistry, February 2022, Elsevier

    Dr Manuel Gómez-Guzmán

  10. Trimethylamine N-Oxide Promotes Autoimmunity and a Loss of Vascular Function in Toll-like Receptor 7-Driven Lupus Mice

    Article • Antioxidants, December 2021, MDPI AG

    Dr Manuel Gómez-Guzmán

  11. Gut Microbiota Has a Crucial Role in the Development of Hypertension and Vascular Dysfunction in Toll-like Receptor 7-Driven Lupus Autoimmunity

    Article • Antioxidants, September 2021, MDPI AG

    Dr Manuel Gómez-Guzmán

  12. Changes in Gut Microbiota Induced by Doxycycline Influence in Vascular Function and Development of Hypertension in DOCA-Salt Rats

    Article • Nutrients, August 2021, MDPI AG

    Dr Manuel Gómez-Guzmán

  13. Probiotics Prevent Hypertension in a Murine Model of Systemic Lupus Erythematosus Induced by Toll-Like Receptor 7 Activation

    Article • Nutrients, July 2021, MDPI AG

    Dr Manuel Gómez-Guzmán

  14. Gut microbiota contributes to the development of hypertension in a genetic mouse model of systemic lupus erythematosus

    Article • British Journal of Pharmacology, June 2021, Wiley

    Dr Manuel Gómez-Guzmán

  15. Results of Development and Application of an Objective Structured Clinical Examination: A Pioneering Experience in Pharmaceutical Care

    Article • Indian Journal of Pharmaceutical Education and Research, May 2021, EManuscript Services

    Dr Manuel Gómez-Guzmán

  16. Mycophenolate mediated remodeling of gut microbiota and improvement of gut-brain axis in spontaneously hypertensive rats

    Article • Biomedicine & Pharmacotherapy, March 2021, Elsevier

    Dr Manuel Gómez-Guzmán

  17. Mycophenolate Improves Brain–Gut Axis Inducing Remodeling of Gut Microbiota in DOCA-Salt Hypertensive Rats

    Article • Antioxidants, November 2020, MDPI AG

    Dr Manuel Gómez-Guzmán

  18. Lockdown, Emotional Intelligence, Academic Engagement and Burnout in Pharmacy Students during the Quarantine

    Article • Pharmacy, October 2020, MDPI AG

    Dr Manuel Gómez-Guzmán

  19. Probiotic Bifidobacterium breve prevents DOCA‐salt hypertension

    Article • The FASEB Journal, August 2020, Wiley

    Dr Manuel Gómez-Guzmán

  20. Probiotics Prevent Dysbiosis and the Rise in Blood Pressure in Genetic Hypertension: Role of Short‐Chain Fatty Acids

    Article • Molecular Nutrition & Food Research, February 2020, Wiley

    Dr Manuel Gómez-Guzmán

  21. Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects

    Article • British Journal of Pharmacology, February 2020, Wiley

    Dr Manuel Gómez-Guzmán

  22. Toll-like receptor 7-driven lupus autoimmunity induces hypertension and vascular alterations in mice

    Article • Journal of Hypertension, January 2020, Wolters Kluwer Health

    Dr Manuel Gómez-Guzmán

  23. Lactobacillus fermentum CECT5716 prevents renal damage in the NZBWF1 mouse model of systemic lupus erythematosus

    Article • Food & Function, January 2020, Royal Society of Chemistry

    Dr Manuel Gómez-Guzmán

  24. Role of the immune system in vascular function and blood pressure control induced by faecal microbiota transplantation in rats

    Article • Acta Physiologica, June 2019, Wiley

    Dr Manuel Gómez-Guzmán

  25. Critical Role of the Interaction Gut Microbiota – Sympathetic Nervous System in the Regulation of Blood Pressure

    Article • Frontiers in Physiology, March 2019, Frontiers

    Dr Manuel Gómez-Guzmán

  26. Cardiovascular effects of flavonoids

    Article • Current Medicinal Chemistry, December 2018, Bentham Science Publishers

    Dr Manuel Gómez-Guzmán

  27. Potential Role of Seaweed Polyphenols in Cardiovascular-Associated Disorders

    Article • Marine Drugs, July 2018, MDPI AG

    Dr Manuel Gómez-Guzmán

  28. THE TEACHING TEAM OF EXPERIENCED AND BEGINNER PROFESSORS CONTRIBUTES TO THE CONTINUOUS IMPROVEMENT OF THE TEACHING IN THE UNIVERSITY OF GRANADA

    Article • July 2018, IATED Academy, S.L.

    Dr Manuel Gómez-Guzmán

  29. The Role of Nrf2 Signaling in PPARβ/δ-Mediated Vascular Protection against Hyperglycemia-Induced Oxidative Stress

    Article • Oxidative Medicine and Cellular Longevity, June 2018, Hindawi Publishing Corporation

    Dr Manuel Gómez-Guzmán, Dr Ayman M Mahmoud, Juan Duarte

  30. Non-muscular myosin light chain kinase triggers intermittent hypoxia-induced interleukin-6 release, endothelial dysfunction and permeability

    Article • Scientific Reports, October 2017, Nature

    Dr Manuel Gómez-Guzmán, Mathieu NITIEMA

  31. Glutamyl aminopeptidase in microvesicular and exosomal fractions of urine is related with renal dysfunction in cisplatin-treated rats

    Article • PLoS ONE, April 2017, PLOS

    Dr Manuel Gómez-Guzmán

  32. Vascular and Central Activation of Peroxisome Proliferator-Activated Receptor-  Attenuates Angiotensin II-Induced Hypertension: Role of RGS-5

    Article • Journal of Pharmacology and Experimental Therapeutics, April 2016, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Manuel Gómez-Guzmán, Juan Duarte

  33. 0180 : Role of non-muscular myosin light chain kinase (nmMLCK) in the inflammation associated with a model of intermittent hypoxia

    Article • Archives of Cardiovascular Diseases Supplements, April 2016, Elsevier

    Dr Manuel Gómez-Guzmán

  34. Antihypertensive effects of oleuropein-enriched olive leaf extract in spontaneously hypertensive rats

    Article • Food & Function, January 2016, Royal Society of Chemistry

    Dr Manuel Gómez-Guzmán, Juan Duarte

  35. Antihypertensive effects of probioticsLactobacillusstrains in spontaneously hypertensive rats

    Article • Molecular Nutrition & Food Research, September 2015, Wiley

    Dr Manuel Gómez-Guzmán, Juan Duarte

  36. Chronic peroxisome proliferator-activated receptorβ/δ agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity

    Article • Journal of Hypertension, September 2015, Wolters Kluwer Health

    Dr Manuel Gómez-Guzmán

  37. Carnitine palmitoyltransferase-1 up-regulation by PPAR-β/δ prevents lipid-induced endothelial dysfunction

    Article • Clinical Science, August 2015, Portland Press Ltd.

    Dr Manuel Gómez-Guzmán

  38. PROTECTIVE EFFECTS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-ss ACTIVATION ON LIPID-INDUCED ENDOTHELIAL DYSFUNCTION via CARNITINE PALMITOYL TRANSFERASE-1 UPREGULATION

    Article • Heart, November 2014, BMJ

    Dr Manuel Gómez-Guzmán

  39. The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice

    Article • Clinical Science, July 2014, Portland Press Ltd.

    Dr Manuel Gómez-Guzmán

  40. PPARβ activation restores the high glucose‐induced impairment of insulin signalling in endothelial cells

    Article • British Journal of Pharmacology, May 2014, Wiley

    Dr Manuel Gómez-Guzmán, Juan Duarte

  41. Chronic Hydroxychloroquine Improves Endothelial Dysfunction and Protects Kidney in a Mouse Model of Systemic Lupus Erythematosus

    Article • Hypertension, May 2014, Wolters Kluwer Health

    Dr Manuel Gómez-Guzmán

  42. Oral Communication Abstracts

    Article • Fundamental and Clinical Pharmacology, April 2014, Wiley

    Dr Manuel Gómez-Guzmán

  43. 0398: Role of non-muscular myosin light chain kinase (nmMLCK) in the inflammation associated with intermittent hypoxia

    Article • Archives of Cardiovascular Diseases Supplements, April 2014, Elsevier

    Dr Manuel Gómez-Guzmán

  44. Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent hypertension

    Article • Cardiovascular Research, June 2013, European Society of Cardiology

    Dr Manuel Gómez-Guzmán

  45. SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: Implications for vascular aging

    Article • Biochemical Pharmacology, May 2013, Elsevier

    Dr Manuel Gómez-Guzmán

  46. Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats

    Article • Free Radical Biology and Medicine, August 2012, Elsevier

    Dr Manuel Gómez-Guzmán

  47. Different cardiovascular protective effects of quercetin administered orally or intraperitoneally in spontaneously hypertensive rats

    Article • Food & Function, January 2012, Royal Society of Chemistry

    Dr Manuel Gómez-Guzmán

  48. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension

    Article • Free Radical Biology and Medicine, January 2012, Elsevier

    Dr Manuel Gómez-Guzmán

  49. Chronic ( − )-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats

    Article • British Journal Of Nutrition, September 2011, Cambridge University Press

    Dr Manuel Gómez-Guzmán

  50. Antihypertensive Effects of Peroxisome Proliferator-Activated Receptor-  Activation in Spontaneously Hypertensive Rats

    Article • Hypertension, August 2011, Wolters Kluwer Health

    Dr Manuel Gómez-Guzmán

  51. Red wine polyphenols prevent endothelial dysfunction induced by endothelin-1 in rat aorta: role of NADPH oxidase

    Article • Clinical Science, April 2011, Portland Press Ltd.

    Dr Manuel Gómez-Guzmán

  52. Endothelium-Dependent Vasodilator Effects of Peroxisome Proliferator-Activated Receptor β Agonists via the Phosphatidyl-Inositol-3 Kinase-Akt Pathway

    Article • Journal of Pharmacology and Experimental Therapeutics, November 2009, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Manuel Gómez-Guzmán

  53. Wine Polyphenols Improve Endothelial Function in Large Vessels of Female Spontaneously Hypertensive Rats

    Article • Hypertension, February 2008, Wolters Kluwer Health

    Dr Manuel Gómez-Guzmán